Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Executive or director change
  2. 8-K Event Material agreement · New debt or obligation · Executive or director change
  3. 8-K Event Executive or director change
  4. 10-Q Report Quarterly Report
  5. 8-K Event Material agreement · Results of operations · New debt or obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
  6. 8-K Event Shareholder vote results
  7. 10-Q Report Quarterly Report
  8. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
  9. 8-K Event Executive or director change
  10. 10-K Report Annual Report
  11. 8-K Event Executive or director change
  12. 8-K Event Results of operations · Exit or restructuring costs · Other events
  13. 8-K Event Material agreement · Executive or director change
  14. 8-K Event Delisting notice
  15. 10-Q Report Quarterly Report
  16. 8-K Event Executive or director change
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Bylaws or fiscal year change · Other events
  19. 8-K Event Executive or director change
  20. 8-K Event Material agreement · New debt or obligation · Executive or director change · Shareholder vote results

Page 4 of 6 · 116 filings